KBLB Kraig Biocraft Laboratories Inc (QB)

Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) announces today that its ticker has changed to KBLB.PK.

The ticker symbol change is the result of the largest market makers changing trading platforms. "Apparently the largest market makers have decided to run their trades through the pink sheet system because of a combination of lower fees and certain computer system upgrades," said CEO Kim Thompson. "The change has nothing to do with our corporate activity. We remain current on all filings and will of course remain a reporting company. Our third quarter just ended a few days ago on September 30th, and we anticipate filing our 10Q in record time for Kraig."

The Company will host a conference call on Friday, October 8 at 4:30 PM EDT. The conference call phone number and other details will be announced in a follow-up company release early Friday. Shareholders are invited to submit questions to benh@ttfsco.com prior to the event.

For more information on Kraig Biocraft Laboratories please visit the Company's web site: http://www.KraigLabs.com.

Statements in this press release about the company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "hopes," "develops," "researching," "research," "potential," "could" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company's financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.

Contact: Ben Hansel (720) 288-8495 Email Contact